MedPath

?Fenoldopam end Renal failure? (FENO-HSR)

Conditions
Renal failure from ipoperfusion post Cardiac surgery
MedDRA version: 14.1Level: LLTClassification code 10000821Term: Acute kidney failureSystem Organ Class: 10038359 - Renal and urinary disorders
MedDRA version: 14.1Level: PTClassification code 10048988Term: Renal artery occlusionSystem Organ Class: 10038359 - Renal and urinary disorders
MedDRA version: 14.1Level: PTClassification code 10002482Term: AngiosclerosisSystem Organ Class: 10047065 - Vascular disorders
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2008-002077-12-IT
Lead Sponsor
AZIENDA OSPEDALIERA DI PERUGIA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Sick undergo intervention cardiochirurgico who develop at any time during the postoperative hospital in Intensive Care, a screzio renal defined as ''R'' of the score of RIFLE (increase in creatinine of 50% compared to preoperatorio cardiochirurgico diuresis or with a less than 0 , 5 ml / kg / h for 6 hours) and a planned hospital in cardiac intensive care exceeding 24 hours). The upside of creatinine can happen at any time of hospitalization in Intensive Care (not necessarily in the first 24-48 hours) for any reason (low flow, sepsis ..).
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

-- Glaucoma -- Provided by the hospital intensive care within 24 hours -- Already taken the decision to place renal replacement treatment -- Already taken the decision not to therapeutic likely exitus -- Inclusion in other protocols randomized -- Age <18 years -- Lack of informed consent -- Patients who received fenoldopam in the previous 30 days -- Preoperative dialysis (temporary or permanent)

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath